Central Nervous System B-Cell Lymphoma in Multiple Sclerosis

被引:2
作者
Lyons, Mark [1 ]
Patel, Naresh [1 ]
Birch, Barry [1 ]
Boucher, Orland [1 ]
机构
[1] Mayo Clin Arizona, Dept Neurol Surg, Phoenix, AZ USA
关键词
Multiple sclerosis; Primary central nervous system lymphoma; Brain biopsy; Interferon; Magnetic resonance imaging; CANCER INCIDENCE; AZATHIOPRINE; DISEASE; METHYLPREDNISOLONE; RISK;
D O I
10.5137/1019-5149.JTN.3860-10.0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The differential diagnosis of multiple sclerosis is extensive and it can be challenging to diagnose initially in the absence of pathognomonic clinical features. Furthermore, these patients can also develop other diseases during their course of treatment, which usually lasts for many years. Some conditions, such as primary central nervous system lymphoma, can mimic clinically some of the symptoms prominent in multiple sclerosis. Early treatment. with corticosteroids can also dramatically improve patient symptoms in both conditions. We report a case of a man diagnosed with histologically confirmed relapsing remitting multiple sclerosis who subsequently developed histologically confirmed primary central nervous system lymphoma. The course of his disease and treatment are presented and the current literature reviewed.
引用
收藏
页码:493 / 495
页数:3
相关论文
共 18 条
[1]   Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments [J].
Achiron, A ;
Barak, Y ;
Gail, M ;
Mandel, M ;
Pee, D ;
Ayyagari, R ;
Rotstein, Z .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (03) :265-270
[2]   GENERAL DISEASE IN 120 NECROPSY-PROVEN CASES OF MULTIPLE-SCLEROSIS [J].
ALLEN, IV ;
MILLAR, JHD ;
HUTCHINSON, MJ .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1978, 4 (04) :279-284
[3]   Non-specific immunosuppressants in the treatment of multiple sclerosis [J].
Confavreux, C ;
Vukusic, S .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (03) :263-269
[4]   PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IMITATES MULTIPLE-SCLEROSIS [J].
DEANGELIS, LM .
JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (02) :177-181
[5]   Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria [J].
Edan, G ;
Miller, D ;
Clanet, M ;
Confavreux, C ;
LyonCaen, O ;
Lubetzki, C ;
Brochet, B ;
Berry, I ;
Rolland, Y ;
Froment, JC ;
Dousset, V ;
Cabanis, E ;
IbaZizen, MT ;
Gandon, JM ;
Lai, HM ;
Moseley, I ;
Sabouraud, O .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (02) :112-118
[6]   A PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-MASKED, VARIABLE DOSAGE, CLINICAL-TRIAL OF AZATHIOPRINE WITH AND WITHOUT METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS [J].
ELLISON, GW ;
MYERS, LW ;
MICKEY, MR ;
GRAVES, MC ;
TOURTELLOTTE, WW ;
SYNDULKO, K ;
HOLEVOETHOWSON, MI ;
LERNER, CD ;
FRANE, MV ;
PETTLERJENNINGS, P .
NEUROLOGY, 1989, 39 (08) :1018-1026
[7]   PATTERNS OF COMORBIDITY IN ELDERLY PATIENTS WITH MULTIPLE-SCLEROSIS [J].
FLEMING, ST ;
BLAKE, RL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (10) :1127-1132
[8]   LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
GOODKIN, DE ;
RUDICK, RA ;
MEDENDORP, SV ;
DAUGHTRY, MM ;
SCHWETZ, KM ;
FISCHER, J ;
VANDYKE, C .
ANNALS OF NEUROLOGY, 1995, 37 (01) :30-40
[9]   BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma [J].
Krumbholz, M ;
Theil, D ;
Derfuss, T ;
Rosenwald, A ;
Schrader, F ;
Monoranu, CM ;
Kalled, SL ;
Hess, DM ;
Serafini, B ;
Aloisi, F ;
Wekerle, H ;
Hohlfeld, R ;
Meinl, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (02) :195-200
[10]   Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis [J].
Lebrun, Christine ;
Debouverie, Marc ;
Vermersch, Patrick ;
Clavelou, Pierre ;
Rumbach, Lucien ;
de Seze, Jerome ;
Wiertlevski, Sandrine ;
Defer, Gilles ;
Gout, Olivier ;
Berthier, Frederic ;
Danzon, Arlette .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (03) :399-405